| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 6M 0.9744% | $1.67 | $10M | -57.66% | ||
| 2018-07-30 | Liquidia Corporation LQDA | 10 percent owner | 545,455 4.6996% | $11.00 | $6M | +38.27% | ||
| 2018-05-10 | Sale | GlycoMimetics, Inc. GLYC | 19,078 0.0446% | $17.81 | $339,779 | -26.95% | ||
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 12M 2.1988% | $1.92 | $23M | -12.28% | ||
| 2018-03-27 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 707,964 4.6641% | $2.70 | $1.91M | -8.89% | ||
| 2018-03-26 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.14M 0.2007% | $1.90 | $2.18M | -14.01% | ||
| 2018-03-23 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 588,180 0.1062% | $1.95 | $1.14M | -12.52% | ||
| 2018-03-22 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.74M 0.308% | $1.90 | $3.31M | -12.12% | ||
| 2018-03-21 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 209,688 0.0355% | $1.81 | $379,640 | -10.61% | ||
| 2017-11-27 | Sale | Appian Corporation APPN | 10 percent owner | 1.14M 2.1156% | $19.49 | $22.2M | +42.78% | |
| 2017-11-20 | Sale | Appian Corporation APPN | 10 percent owner | 5.64M 11.2735% | $19.49 | $109.94M | +53.66% | |
| 2017-10-10 | Rhythm Pharmaceuticals, Inc. RYTM | 10 percent owner | 550,000 1.3734% | $17.00 | $9.35M | +9.57% | ||
| 2017-07-03 | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 2M 9.7597% | $15.00 | $30M | +20.77% | ||
| 2017-06-01 | Senseonics Holdings, Inc. SENS | 7.09M 6.8398% | $1.41 | $10M | +99.29% | |||
| 2017-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 25.74M 5.5147% | $0.70 | $18.02M | +55.36% | ||
| 2016-11-29 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 869,565 6.1674% | $5.75 | $5M | -41.3% | ||
| 2016-07-18 | Ardelyx, Inc. ARDX | 10 percent owner | 1.53M 2.9762% | $8.73 | $13.33M | +25.38% | ||
| 2016-03-23 | Senseonics Holdings, Inc. SENS | 1.58M 2.0277% | $2.85 | $4.5M | +11.5% | |||
| 2016-01-13 | Ardelyx, Inc. ARDX | 10 percent owner | 1M 3.0335% | $10.00 | $10M | +4.47% | ||
| 2015-12-08 | Sale | Supernus Pharmaceuticals, Inc. SUPN | director | 70,913 0.1444% | $14.75 | $1.05M | +26.72% |